Aspirion, a technology-enabled healthcare revenue cycle management ("RCM") provider for complex claims and revenue integrity, announced today that it has named Amy Amick as Chief Executive Officer, effective April 17. Amick is an accomplished executive with a track record of leading and transforming healthcare technology businesses providing RCM, analytics, patient engagement, population health, and electronic health records software to healthcare providers globally.

 "I am honored to join the Aspirion team. Since inception, Aspirion has done a remarkable job of recovering billions in revenue for its clients and establishing trusted, value-based relationships," said Amick. "I look forward to helping Aspirion build on this strong foundation to deliver next generation reimbursement solutions which allow our healthcare provider clients to focus on delivering and improving patient care. It is an exciting time in the industry, and we are capitalizing on our existing investments and rapid advancements in AI and machine learning which are already improving many aspects of Aspirion's and therefore, our clients' operations."

"We are excited to have Amy join as CEO. We believe she is an exceptional leader with the vision and experience to continue propelling Aspirion forward with a combination of technology innovation and a commitment to client success that she has been known for during her career," said Richard Thomas, Aspirion's Chairman of the Board and Linden Operating Partner. "On behalf of everyone at Aspirion, we welcome Amy to the team and offer our thanks to interim-CEO, Linden Operating Partner, and board member Miki Kapoor."